Combination therapy with anti-HIV-1 antibodies maintains viral suppression

Combination therapy with anti-HIV-1 antibodies maintains viral suppression

Combination therapy with anti-HIV-1 antibodies maintains viral suppression, Published online: 26 September 2018; doi:10.1038/s41586-018-0531-2

Combination therapy with the anti-HIV-1 monoclonal antibodies 3BNC117 and 10-1074 maintains long-term suppression in the absence of antiretroviral therapy in individuals with antibody-sensitive viral reservoirs.

from Nature - Issue - nature.com science feeds https://ift.tt/2OZdHNO